Literature DB >> 24392577

Age related interaction of dopamine and serotonin synthesis in striatal synaptosomes.

Manoochehr Messripour1, Azadeh Mesripour2.   

Abstract

Tyrosine hydroxylase and tryptophan hydroxylase are key rate limiting enzymes in the biosynthesis of dopamine and serotonin, respectively. Since both enzymes are active in striatum, and affected by age, this study was undertaken to investigate interaction between dopamine and serotonin synthesis in brain striatal synaptosomes of aging rat. Male Wistar rats (3 and 30 month old) were killed by decapitation and brain striatal synaptosomes were prepared by discontinuous Ficoll/sucrose gradient technique. Synaptosomes were incubated in the presence of added pargiline (monoamineoxidase inhibitor), dopamine or serotonin synthesized during 25 min was measured by HPLC, employing electrochemical detection. Dopamine synthesis in synaptosomes prepared from young animals was markedly inhibited by addition of 5 microM serotonin concentrations (30%) and increasing serotonin concentrations up to 50 microM caused only a smaller additional inhibition. Dopamine synthesis in synaptosomes obtained from old rats was significantly lower than that of youg animals and addition of serotonin concentrations up to 50 microM had little effect on these preparations. In case of serotonin synthesis, exogenously added 5 microM dopamine inhibited serotonin synthesis in the synaptosomes of both ages by about 40%, whereas with higher concentration of dopamine (10-50 microM) the rate of inhibition was highly pronounced in old rats as compared to that of young animals. It is concluded that dopamine and serotonin interaction may be significant, and that these should be considered in long-term treatments of Parkinson's disease with L-DOPA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24392577

Source DB:  PubMed          Journal:  Biocell        ISSN: 0327-9545            Impact factor:   1.254


  6 in total

1.  β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease.

Authors:  Shreesh Ojha; Hayate Javed; Sheikh Azimullah; M Emdadul Haque
Journal:  Mol Cell Biochem       Date:  2016-06-17       Impact factor: 3.396

2.  Nanotechnology-based drug delivery of ropinirole for Parkinson's disease.

Authors:  Emilia Barcia; Liudmila Boeva; Luis García-García; Karla Slowing; Ana Fernández-Carballido; Yaquelyn Casanova; Sofía Negro
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Protective effects of a polysaccharide from Spirulina platensis on dopaminergic neurons in an MPTP-induced Parkinson's disease model in C57BL/6J mice.

Authors:  Fang Zhang; Jian Lu; Ji-Guo Zhang; Jun-Xia Xie
Journal:  Neural Regen Res       Date:  2015-02       Impact factor: 5.135

4.  Serotonergic activation during courtship and aggression in the brown anole, Anolis sagrei.

Authors:  Jacob T Hartline; Alexandra N Smith; David Kabelik
Journal:  PeerJ       Date:  2017-05-16       Impact factor: 2.984

5.  Neuroprotective effect of arctigenin against neuroinflammation and oxidative stress induced by rotenone.

Authors:  Na Zhang; Deqiang Dou; Xiaoku Ran; Tingguo Kang
Journal:  RSC Adv       Date:  2018-01-10       Impact factor: 4.036

6.  Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.

Authors:  Hayate Javed; Sheikh Azimullah; Salema B Abul Khair; Shreesh Ojha; M Emdadul Haque
Journal:  BMC Neurosci       Date:  2016-08-22       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.